CD83 and Crohn disease: The Newcastle University RA (Dex + Vit D3) and the Crohn’s disease (Dex) trials both reported decreased CD83 expression, high CD86 expression, decreased IL-12 secretion, and elevated IL-10 secretion in their tDC products suggesting a possible tDC shared phenotype.